FACEITSync Branding FACEITSync
RobOne_

RobOne_ - FACEIT level 10, 2,059 ELO

IE
200 matches tracked 40 matches in 30 days
ELO
2,059
30-day peak: 2,099
History
Rank EU
#198,706
IE #348 in IE
Last updated:

RobOne_ at a glance

Level 10 2,059 ELO best map Nuke (65%)
Period Last 199 Season 9 30 days Last 20
2,001-2,249 ELO

Last 20 matches compared with 2,997 players in this group: K/R and ADR below average, win rate above average.

RatingCalculated with the HLTV Rating 1.0 formula from kills, deaths and multi-kills per round. 1.00 is an average match.
better than 32%
0.97
SpreadHow much the rating swings from match to match. The smaller, the more consistent. ±0.28 ConsistencyShare of matches with a rating of 0.90 or higher. 50%
K/R
0.70
better than 34% of players
2,001-2,249 ELO avg: 0.73
Last 12 months
ADR
76.1
better than 30% of players
2,001-2,249 ELO avg: 80.2
Last 12 months
Win rate
60%
better than 78% of players
2,001-2,249 ELO avg: 49%
Last 12 months

Form

to

12 wins · 8 losses · +37 ELO
olderlatest match

Facts

208 ELO Next goal ELO to the peak (2,267)
2 W · 1 L Best day +28 ELO · Sep 25, 2026
Ancient Favorite map 55 of 199 matches
Nuke 65% Map pool tip weakest: Anubis 36%
18:00-23:00 Playing times
On Fridays Best time 67% win rate vs. 51%
FormMapsTiming

208 ELO away from the recorded peak (2,267). 2:1 on Sep 25, 2026 (+28 ELO, last 90 days). Most played: Ancient (55 of 199 matches). Strongest map: Nuke (65% win rate, 20 matches). Weakest: Anubis (36%, 11 matches). Plays most between 18:00 and 23:00 (based on 199 matches). Best results on Fridays: 67% win rate vs. 51% overall (33 matches).

About RobOne_

RobOne_ plays CS2 on FACEIT level 10 with 2,059 ELO. The stats cover 199 matches. The strongest map is Nuke with a 65% win rate in 20 matches. Most played: Ancient with 55 matches and a 45% win rate. Biggest strength: Utility damage per round at 6.2, better than 89% of level 10 · 2,001-2,249 ELO players. Last 20 matches: 12 wins, 8 losses, +37 ELO. RobOne_ does best on Fridays: 67% win rate in 33 matches.